Hspital de la Santa Creu i Sant Pau
Barcelona, Catalonia, 08025, Spain
NCT Number: NCT03532724
ORION is a retrospective, observational, one center study to evaluate the incidence of complications (both thromboembolic and bleedings) in a cohort of patients receiving Vitamin K antagonists (VKA) under a self-management program, since 2002 at the Hospital de la Santa Creu i Sant Pau in Barcelona (Spain)
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Barcelona, Catalonia, 08025, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Trained patients check weekly the INR using a portable coagulometer an decide by themselves the dosis of VKA
Time frame: since 1 of july of 2002 to 30th of june of 2018
Any documented embolic stroke, peripheral arterial embolism or venous thromboembolism
Time frame: since 1 of july of 2002 to 30th of june of 2018
Any documented bleeding event grade 3 or 5 in the Bleeding Assessment Research Consortium (BARC) scale
Time frame: since 1 of july of 2002 to 30th of june of 2018
Death from any cause
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Other
Retrospective Analysis of the Clinical Outcomes From Patient Self-management of Antivitamin K Treatment at the Hospitald de Sant Pau. ORION Study
Acronym: ORION
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.